Otsuka Pharmaceutical Appoints New Director on Board

Otsuka Welfare Clinic awarded special commendation
by the Ambassador of Japan in Pakistan
Otsuka Welfare Clinic recognized for providing treatment over the past eight years to Afghan refugees in Pakistan

Survey of bowel movements and fiber intake among children Approximately 40% of elementary school children do not have daily bowel movements Approximately 60% of mothers in this group feel their children lack fiber

NEW DRUG APPLICATION FOR OTSUKA’S ONCE-MONTHLY ARIPIPRAZOLE DEPOT FORMULATION FOR MAINTENANCE TREATMENT OF ADULT PATIENTS WITH SCHIZOPHRENIA ACCEPTED FOR REVIEW BY THE U.S. FOOD AND DRUG ADMINISTRATION

Streptococcus pneumoniae Kit “RAPIRUN S. pneumoniae HS (otitis media/sinusitis)” as in vitro diagnostic releases on December 1

Tokushima Itano Factory jointly Sponsors Asan Walking Festival in Itano and Appeals for the Importance of Environmental Protection and Health

OTSUKA PHARMACEUTICAL CO., LTD. AND H. LUNDBECK A/S Sign Historic Agreement to Deliver Innovative Medicines with Focus on Psychiatric Disorders Worldwide

Results of two trials show a rapid and sustained response with certolizumab pegol for treatment of rheumatoid arthritis (J-RAPID and HIKARI Studies) released at 2011 meeting of American College of Rheumatology (ACR)

Amino-Value Used as the Official Drink of the Osaka Marathon 2011 Otsuka Pharmaceutical is Now Supporting Two of Japan’s Largest Civic Marathons Amidst an Unprecedented Boom in Popularity in Japan

Otsuka Pharmaceutical Confirmed Clinical Efficacy of Rotigotine Transdermal System for Restless Legs Syndrome in Phase III Clinical Study in Japan

～Easy Meal Replacement for Calorie Control ～
No. 1* French Diet Food Market Brand Gerlinéa Launches Cereal Bar in Chocolate and Vanilla Flavors

Low-GI biscuit packed with fiber and bursting with five-grain cereal crunch Gérble GLUCOSANTE Launches on October 3

Healthy hair begins with a healthy scalp. Start your care routine from the scalp with UL･OS.
UL・OS Scalp Shampoo（Medicated Cosmetic）Launches on September 13

Notice Regarding Change of Director on Board

How much exercise intensity does trail walking in the mountains place on middle-aged and elderly people? Mountain climbing research suggests possibility of BCAA supplementation having "muscle fatigue inhibitory effect"

The Core of Globally Expanding Drug Discovery Research 10th Research Center wins the "Nikkei New Office Promotion Award" The Creativity-producing Office Space is Evaluated

25,000 People Gather in Hilly Town of 10,000 for Free Live Concert Held at Tokushima Wajiki Factory Event Dedicated to Vitalization of Local Community

Otsuka Pharmaceutical Establishes Special Subsidiary Company, Heartful Kawauchi Co., Ltd., in Tokushima City to Promote Employment of Persons with Disabilities

In-vitro Diagnostic Kit, WT1 mRNA Assay Kit 'Otsuka' is Covered under Japanese Insurance Program, effective as of August.

Partner Agreement Concluded
between WASEDA University Athletic Center and Otsuka Pharmaceutical

The IFPMA Welcomes Otsuka Pharmaceutical as New Member to advance Global Health

Otsuka Pharmaceutical Appoints Two Female Operating Officers for the First Time in the History of Its Pharmaceutical Business

Otsuka Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors

Anti-cancer agent "Sprycel® 20mg Tablets and Sprycel® 50mg Tablets (dasatinib)" approved as the first-line treatment of chronic myeloid leukemia

Otsuka receives approval for Streptococcus pneumoniae Kit “RAPIRUN S. pneumoniae HS (otitis media/sinusitis)” as in vitro diagnostic on June 13

Otsuka Pharmaceutical confirmed clinical efficacy of rotigotine trandermal system in Phase III clinical study in patients with advanced Parkinson's disease in Japan

America's Number One-selling Vitamin, Mineral and Supplement Brand Five Years Running - Nature Made New Series Providing Nutritional Support in a Single Pill Taken Daily Super Multiple Vitamin & Minerals and Super Fish Oil Set for June 6 Release

Oronamin-C Drink
First Small-Volume Vitamin Drink in Japan to Exceed 30 Billion Bottles in Accumulated Sales

Gerlinéa, the No. 1 brand for French Diet Food market
～Easy and Enjoyment; French Style Calorie Control～
Test Marketing Begins June 2, 2011 in Shizuoka and Tokyo

Otsuka Pharmaceutical Establishes Subsidiary, Otsuka SA, to Facilitate Public Advocacy for the Company’s Global Tuberculosis Program

OTSUKA PHARMACEUTICAL CO., LTD. ANNOUNCES RESULTS FROM A PHASE 2 STUDY OF INVESTIGATIONAL PRODUCT OPC-34712 AS ADJUNCTIVE THERAPY IN ADULTS WITH MAJOR DEPRESSIVE DISORDER

Phase III Study Results for Rebamipide Ophthalmic Suspension for Dry Eye Announced at ARVO 2011

Handy Skin Care for Active Men
UL・OS Refresh Sheet (Medicated Cosmetic) Launches on April 21

Otsuka Pharmaceutical Received Approval for Additional Indication of L-Cartin® tablets for Carnitine Deficiency in Japan

Otsuka Pharmaceutical Announces Changes to Board Members

SOYJOY Fruity Tomato, a New Combination of Soy and Tomato, Launches on April 11

ABILIFY®(aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate

Tokushima Itano Factory Awarded
"Excellent Energy Management Factory" Commendation from
Chief of Shikoku Bureau of Economy, Trade and Industry
Achieves roughly 3.5% reduction in energy consumption efficiency unit

In-vitro Diagnostic Kit, WT1 mRNA Assay Kit 'Otsuka' Received Regulatory Approval for Additional Purpose of Use with Myelodysplastic Syndromes

Otsuka Foods and Otsuka Pharmaceutical to Partner with ITO EN
on Cross-Sales of Products in Vending Machines

Sparkling Soy Water SOYSH
Internet Buzz Leads to Its Distribution to Stores Nationwide in Japan Starting March 14, 2011

Otsuka Announces Initiation of Phase II Clinical Trials for Angiogenesis Inhibitor OCV-101

Nutraceutical Business in Europe Moves to New Stage SOYJOY, the First Japanese Product, Set to Debut in 4 Countries

Otsuka Pharmaceutical Files for Additional Indication Regulatory Approval in Japan for ABILIFY®, a Treatment for the Manic Symptoms Associated with Bipolar Disorder

Amino-Value set to be the Official Drink of the Tokyo Marathon 2011 Support to Range from Training to Race Day